The AT 1 angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol

Synapse

Volumn 65, Issue 6, 2011, Pages 505-512

  Paz, Maria Constanza ^a   Assis, Maria Amparo ^a   Cabrera, Ricardo J ^b   Cancela, Liliana M ^a   Bregonzio, Claudia ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

Author keywords

Amphetamine; Angiotensin; AT 1 receptors; Sensitization

Indexed keywords

AMPHETAMINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; POTASSIUM; QUINPIROLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL SCIENCE; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG EFFECT; IN VITRO STUDY; LOCOMOTION; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAPERITONEAL; MALE; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 79953284855     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20868     Document Type: Article

References (43)

1. Badiani A, Robinson TE. 2004. Drug-induced neurobehavioral plasticity: The role of environmental context. Behav Pharmacol 15: 327-339.
2. Bregonzio C, Seltzer A, Armando I, Pavel J, Saavedra JM. 2008. Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats. Stress 11: 457-466.
3. Brown DC, Steward LJ, Ge J, Barnes NM. 1996. Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo. Br J Pharmacol 118: 414-420.
4. Cabrera RJ, Navarro CE. 1996. Progesterone in vitro increases NMDA-evoked [3H] dopamine release from striatal slices in proestrus rats. Neuropharmacology 35: 175-178.
5. Darracq L, Blanc G, Glowinski J, Tassin JP. 1998. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci 18: 2729-2739.
6. Devoto P, Flore G, Saba P, Fa M, Gessa GL. 2005. Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus. BMC Neurosci 6: 31.
7. Dias C, Lachize S, Boilet V, Huitelec E, Cador M. 2004. Differential effects of dopaminergic agents on locomotor sensitisation and on the reinstatement of cocaine-seeking and food-seeking behaviour. Psychopharmacology (Berl) 175: 414-427.
8. Felszeghy K, Espinosa JM, Scarna H, Bérod A, Rostène W, Pélaprat D. 2007. Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference. Neuropsychopharmacology 32: 2601-2610.
9. Fitzsimons JT, Setler PE. 1975. The relative importance of central catecholaminergic and cholinergic mechanism in drinking in response to angiotensin and other thirst stimuli. J Physiol 250: 613-631.
10. Georgiev V, Stancheva S, Kambourova T, Getova D. 1990. Effect of angiotensin II on the Vogel conflict paradigm and on the content of dopamine and noradrenaline in rat brain. Acta Physiol Pharmacol Bulg 16: 32-37.
11. Grenhoff J, Svensson TH. 1993. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 233: 79-84.
12. Grenhoff J, North RA, Johnson SW. 1995. Alpha 1-adrenergic effects on dopamine neurons recorded intracellularly in the rat midbrain slice. Eur J Neurosci 7: 1707-1713.
13. Gresch PJ, Sved AF, Zigmond MJ, Finlay JM. 1995. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 65: 111-116.
14. Hoebel BG, Rada P, Mark GP, Hernandez L. 1994. The power of integrative peptides to reinforce behavior by releasing dopamine. Ann N Y Acad Sci 739: 36-41.
15. Huang BS, Malvin RL. 1988. Dopaminergic modulation of some central actions of angiotensin II in vivo. Proc Social Exp Biol Med 188: 405-409.
16. Jackson HC, Nutt DJ. 1993. A single preexposure produces sensitization to the locomotor effects of cocaine in mice. Pharmacol Biochem Behav 45: 733-735.
17. Kalivas PW. 2007. Cocaine and amphetamine-like psychostimulants: Neurocircuitry and glutamate neuroplasticity. Dialogues Clin Neurosci 9: 389-397.
18. Kalivas PW, Stewart J. 1991. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 417: 223-244.
19. Nicolaidis S. 1974. Role des recepteurs internes et externes dans la prise d'eau regulatrice et non regulatrice. In Rein et Foie, Maladies de la Nutrition. 159-174.
20. Pacchioni AM, Cador M, Bregonzio C, Cancela LM. 2007. A glutamate-dopamine interaction in the persistent enhanced response to amphetamine in nucleus accumbens core but not shell following a single restraint stress. Neuropsychopharmacology 32: 682-692.
21. Pierce RC, Kalivas PW. 1997. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25: 192-216.
22. Raghavendra V, Chopra K, Kulkarni SK. 1998. Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan. Neuropeptides 32: 275-280.
23. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18: 247-291.
24. Robinson TE, Berridge KC. 2000. The psychology and neurobiology of addiction: An incentive-sensitization view. Addiction 95 ( Suppl 2): S91-S117.
25. Robinson TE, Kolb B. 1997. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 17: 8491-8497.
26. Robinson TE, Kolb B. 2004. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47 ( Suppl 1): 33-46.
27. Robinson TE, Becker JB, Presty SK. 1982. Long-term facilitation of amphetamine-induced rotational behavior and striatal dopamine release produced by a single exposure to amphetamine: Sex differences. Brain Res 253: 231-241.
28. Robinson TE, Jurson PA, Bennett JA, Bentgen KM. 1988. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: A microdialysis study in freely moving rats. Brain Res 462: 211-222.
29. Rossi NF. 1998. Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro. Am J Physiol 275: 687-693.
30. Saavedra JM, Ando H, Armando I, Baiardi G, Bregonzio C, Juorio A, Macova M. 2005. Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Regul Pept 128: 227-238.
31. Schoffelmeer AN, De Vries TJ, Wardeh G, van de Ven HW, Vanderschuren LJ. 2002. Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J Neurosci 22: 3269-3276.
32. Simonnet G, Giorguieff-Chesselet MF. 1979. Stimulating effect of angiotensin II on the spontaneous release of newly synthetized [3H]dopamine in rat striatal slices. Neurosci Lett 15: 153-158.
33. Simonnet G, Giorguieff-Chesselet MF, Carayon A, Bioulac B, Cesselin F, Glowinski J, Vincent JD. 1981. Angiotensin II and nigostriatal system. J Physiol (Paris) 77: 71-79.
34. Steele MK, McCann SM, Negro-Vilar A. 1982. Modulation by dopamine and estradiol of the central effects of angiotensin II on anterior pituitary hormone release. Endocrinology 111: 722-729.
35. Stewart J, Badiani A. 1993. Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4: 289-312.
36. Tchekalarova J, Georgiev V. 1998. Further evidence for interaction between angiotensin II and dopamine receptors (Experiments on apomorphine stereotypy). Methods Find Exp Clin Pharmacol 20: 419-424.
37. Valjent E, Bertran-Gonzalez J, Aubier B, Greengard P, Herve D, Girault JA. 2010. Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol. Neuropsychopharmacology 35: 401-415.
38. Vanderschuren LJ, Kalivas PW. 2000. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: A critical review of preclinical studies. Psychopharmacology (Berl) 151: 99-120.
39. Vanderschuren LJ, Schmidt ED, De Vries TJ, Van Moorsel CA, Tilders FJ, Schoffelmeer AN. 1999a. A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J Neurosci 19: 9579-9586.
40. Vanderschuren LJ, Schoffelmeer AN, Mulder AH, De Vries TJ. 1999b. Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine. Psychopharmacology (Berl) 143: 244-253.
41. Vanderschuren LJ, Beemster P, Schoffelmeer AN. 2003. On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization. Psychopharmacology (Berl) 169: 176-185.
42. Ventura R, Cabib S, Alcaro A, Orsini C, Puglisi-Allegra S. 2003. Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. J Neurosci 23: 1879-1885.
43. Vezina P, Lorrain DS, Arnold GM, Austin JD, Suto N. 2002. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci 22: 4654-4662.